• 1
    Riff LJ, Thomason JL. Comparative aminoglycoside inactivation by beta-lactam antibiotics. J Antibiot 1982; 35: 850857.
  • 2
    Glew RH, Pavuk RA. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics. Antimicrob Agents Chemother 1983; 24: 474477.
  • 3
    O'Bey KA, Kim LK, Gee JP, Johnson RM. Temperature dependence of the stability of tobramycin mixed with penicillins in human serum. Am J Hosp Pharm 1982; 39: 10051008.
  • 4
    Pickering LK, Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmac exp Ther 1981; 217: 345349.
  • 5
    Hale DC, Jenkins R, Matsen JM. In vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin. Am J clin Path 1980; 74: 316319.
  • 6
    Ebert SC, Jorgensen JH, Drutz DJ, Clement WA. Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods. J clin Microbiol 1984; 20: 701705.
  • 7
    Benveniste R, Davies J. Structure activity relationships among the aminoglycoside antibiotics: role of amino and hydroxyl groups. Antimicrob Agents Chemother 1973; 4: 402409.
  • 8
    Chow MSS, Quintiliani R, Nightingale CH. In vivo inactivation of tobramycin by ticarcillin. J Am med Ass 1982; 247: 658659.
  • 9
    Polk RE, Kline BJ. Mail order tobramycin serum levels: low values caused by ticarcillin. Am J Hosp Pharm 1980; 37: 920921.
  • 10
    Ervin FR, Bullock WE, Nuttall CE. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother 1976; 9: 10041011.
  • 11
    Lau A, Lee M, Flascha S, Prasad R, Sharifi R. Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function. Antimicrob Agents Chemother 1983; 24: 533537.
  • 12
    Sawchuck RJ, Zaske DE, Cipolle RJ, Wargin WA, Strate RG. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmac Ther 1977; 21: 362369.
  • 13
    Pfaller MA, Granich GG, Valdes R, Murray PR. Comparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibiotics. Diagn Microbiol Infect Dis 1984; 2: 93100.
  • 14
    Anders RJZ, Lau A, Sharifi R, Lee M. Comparison of EMIT versus bioassay to evaluate inactivation of tobramycin by piperacillin. Ther Drug Monit 1987; 9: 472477.
  • 15
    Pieper JA, Vidal RA, Schentag JJ. Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions. Antimicrob Agents Chemother 1980; 18: 604609.
  • 16
    Roberts GW, Nation RL, Jarvinen AO. Measurement of serum tobramycin in the presence of ticarcillin or piperacillin. Aust J Hosp Pharm 1992; 22: 152154.
  • 17
    Kildoo CW, Harralson AF, Folli HL, Kelly PC, Nussbaum E. Direct determination of clearance in patients with mild-to-moderate cystic fibrosis. Drug Intell clin Pharm 1987; 21: 639641.
  • 18
    Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B. Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled study. J Pediatr 1984; 105: 117124.
  • 19
    Munzenberger PJ, Commissaris RL, Massoud N & Man-Ching H. Variability of tobramycin pharmacokinetics in cystic fibrosis. Pediatr Infect Dis J 1987; 6: 739743.
  • 20
    Pleasants RA, Williams DM, Waltner WE, Knowles MR. Influence of infusion method on serum tobramycin concentrations in adults with cystic fibrosis. Clin Pharm 1990; 9: 541545.
  • 21
    McEvoy GK, Litvak K. Ticarcillin disodium. In AHFS Drug Information 92, McEvoy GK, Litvak K. eds 1992; pp 299301. Bethesda: American Society of Hospital Pharmacists.
  • 22
    Konishi H, Goto M, Nakamoto Y, Yamamoto I, Yamashina H. Tobramycin inactivation by carbenicillin, ticarcillin and piperacillin. Antimicrob Agents Chemother 1983; 23: 653657.